Please enable Javascript to use all features and improve your user experience.
EHC 2023
Programme
People
Search
DE
Poster
P019
Benefit-Risk assessment of atogepant vs. placebo in participants with episodic migraine who had prior inadequate response to 2–4 classes of oral preventive treatment: a post-hoc analysis of the ELEVATE trial
Presented in
ePoster 02
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy